{
    "title": "Copycat medicine sales hit AstraZeneca, as profits drop 22%, with competition also seen eating into earnings this year",
    "url": "https://www.dailymail.co.uk/money/markets/article-2552954/Copycat-medicine-sales-impact-AstraZeneca-results-2013.html",
    "date": "2014-02-06",
    "keywords": [
        "competition",
        "year",
        "cent",
        "soriot",
        "growth",
        "line",
        "revenue",
        "copycat",
        "medicine",
        "mail",
        "gmt",
        "view",
        "astrazeneca",
        "slump",
        "bestselling",
        "drugmaker",
        "trading",
        "closing",
        "executive",
        "pipeline",
        "priority",
        "deal",
        "control",
        "venture",
        "az",
        "cash",
        "heart",
        "drug",
        "term",
        "fall",
        "exchange",
        "core",
        "firm",
        "performance",
        "loss",
        "exclusivity",
        "salessoriot",
        "forecast",
        "restructuring",
        "part",
        "top",
        "staff",
        "macclesfield",
        "alderley",
        "park",
        "brennan",
        "company",
        "treatment",
        "seroquel",
        "crestor",
        "cholesterol",
        "latestage",
        "number",
        "phase",
        "iii"
    ],
    "category": [
        "money",
        "markets"
    ]
}